Greenwich LifeSciences (GLSI) executive Patel bought 1,000 shares for $9,970 at $9.97
Insider transactions reported
Snehal Patel (executive at Greenwich LifeSciences Inc., GLSI) reported that they bought 1,000 shares for $9,970 at $9.97 on Aug 22, 2023. After these transactions the filing shows 5,291,177 shares held directly.
- Reporting person
- Patel Snehal
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Aug 22, 2023 | Open-market purchase (P) | Common Stock | +1,000 | $9.97 | $9,970 | 5,291,177 direct |
Holdings before and after
- Common Stock: 5,290,177 to 5,291,177 direct
Transaction codes in this filing
- Open-market purchase:
- Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
FAQ
What did Patel report in this GLSI Form 4?
Snehal Patel (executive at Greenwich LifeSciences Inc., GLSI) reported that they bought 1,000 shares for $9,970 at $9.97 on Aug 22, 2023. After these transactions the filing shows 5,291,177 shares held directly.
How many GLSI shares does Patel hold after this filing?
The filing shows 5,291,177 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code P mean on an SEC Form 4?
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Historical context for GLSI
Earlier insider filings at GLSI
- Aug 8, 2023SEC Form 4: Patel Snehal bought $21,100 worth of shares (2,000 units at $10.55), increasing direct ownership by 0.04% to 5,290,177 units
- Jul 25, 2023SEC Form 4 filed by Patel Snehal
- Jul 17, 2023SEC Form 4 filed by Thompson Jaye
- May 18, 2023SEC Form 4 filed by Patel Snehal
- May 2, 2023SEC Form 4 filed by Thompson Jaye
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2020
Follow GLSI and get a push notification the moment its next story breaks.